Understanding Your Risk: A Guide to Breast Cancer Recurrence Testing

Description

Part 1 of a 2-Part Sharsheret Webinar Series

Location

Zoom Link Sent Upon Registration

Date & Time

Wednesday, August 5, 2026 8pm ET/5pm PT

 

 

If you or someone you love has been diagnosed with breast cancer, you may have heard terms like Prosigna, TrueMRD, Oncotype, MammaPrint, and Precise - but what do these tests actually mean, and how do they help guide treatment decisions?

Join Sharsheret for Part 1 of our two-part webinar series on risk of recurrence, where Dr. Noam Drazin, MD will walk us through the landscape of genomic and recurrence risk testing: what each test measures, how results are used, and what questions to ask your medical team.

Bonus for our Embrace Community: We invite members of our Embrace community, those facing metastatic breast cancer or advanced ovarian cancer, to stay on at the end of the webinar for an intimate breakout session with our expert and Bonnie Beckoff, Director of Sharsheret Support Services.

 

Questions? Contact Melanie Fisher at [email protected].

 

With support from:

Cooperative Agreement 24-0061 from the Centers for Disease Control and Prevention

Sponsors: Veracyte, ,

 

*Disclaimer:

By joining this program I understand and acknowledge that Sharsheret is not providing medical advice. Additionally, I release and waive Sharsheret from any liability in the event of any accident or injury I may incur either during the course of this webinar or in performing any of the activities discussed during the same.
 
All views shared on the webinar are of the speakers and are independent of the program sponsors. To the best knowledge of Sharsheret, no relationship exists between the sponsors and the speakers, and no payment has or will be made by the sponsor to the speakers in connection with this webinar.

 

 

Register
Details
Disclaimer is listed at the bottom of the page.
This field is required.
This field is required.
This field is required.
This field is required.